Approval · Notice of Compliance 38206 · 2026
NB-EZETIMIBE: Notice of Compliance 38206
Issued August 31, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38206
- Date
- August 31, 2026
- Company
- NB Pharma Inc.Québec, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers
- Canadian reference product
- EZETROL
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NB-EZETIMIBE | 02571218 | Approved |
Medicinal ingredients
- EZETIMIBE 10 MG per TAB